8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $8M | -$18M | 0.0% | -279.5% | -$16M | $6M | $75M |
| 2024 | $103204 | -$33M | 0.0% | -34835.4% | -$30M | $18M | $85M |
| 2023 | $18M | -$19M | 0.0% | -131.0% | -$29M | $22M | $110M |
| 2022 | $9M | -$80M | 0.0% | -903.1% | -$49M | $28M | $144M |
| 2021 | $10M | -$73M | 0.0% | -711.2% | -$46M | $7M | $174M |
| 2020 | $700913 | -$42M | 0.0% | -6156.5% | -$29M | $8M | $75M |
| 2019 | $480000 | -$16M | 0.0% | -3993.7% | -$18M | $3M | $93M |
| 2018 | $2M | -$15M | 0.0% | -1147.1% | -$15M | — | — |
How the market has priced ADAG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Adagene Inc.'s revenue has grown 61.4% per year. These are computed facts, not advice.
As of FY2025, Adagene Inc. reported $6M of total debt against $75M of cash; operating income covered interest expense -46.3×.
In FY2025, gross margin was —, operating margin -279.5%, and net margin -229.6%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.